Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Manuscript Transfer Facility

If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.

Transfer of Submission

Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.

Step 1.

The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.

Step 2.

The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.

Step 3.

The Author then receives an editorial decision from the journal.

Selection of another Journal

The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.

Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.


Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog